Ending Chemical Abortions Act of 2025
Sponsor
Full profile: /officials/O000175
Source: Congress.gov · FEC
Cosponsors (21)
Members who have signed on to support this bill since introduction. Source: Congress.gov.
21 cosponsors on record at Congress.gov. The named list is syncing into Govwatch and will appear here shortly — view on Congress.gov in the meantime.
Latest Action
The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →
Committee Activity
Currently in
- House Committee on the JudiciaryReferred To · 2025-01-22
Plain-English Summary
This legislation would restrict access to mifepristone, a medication used in medication abortion, by limiting how it can be prescribed and distributed. The bill would affect women seeking abortion services, healthcare providers who offer medication abortion, and pharmaceutical companies that manufacture or distribute the drug. The measure has been referred to the House Judiciary Committee for consideration.
AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.
Subjects
Related legislation
Bills by the same sponsor or covering overlapping subjects.
- HR6808To designate the facility of the United States Postal Service located at 417 West 7th Street in Columbia, Tennessee, as the "Pharmacist’s Mate First Class John Harlan Willis Post Office Building".Passed House · 2026-09-14
- HRES1472Impeaching Allison Dale Burroughs, a judge of the United States District Court for the District of Massachusetts, for high crimes and misdemeanors.Referred to Committee · 2026-08-03
- HR9968Opening Programs to Organic Farms ActReferred to Committee · 2026-07-27
- HR9868Preventing Forced Abortions Act of 2026Referred to Committee · 2026-07-22